Goat Anti-Rabbit IgG (H+L) Antibody (HRP)

Katalognummer

LDG0014YE

Datenblatt

Weitere Dokumente

Paket & Preis werden geladen...

COA-Suche

• Übersicht

  Beschreibung

  Leadgene Goat Anti-Rabbit IgG (H+L) Antibody (HRP) is conjugated with high-activity horseradish peroxidase (HRP).

  Produktnotiz

  Recommended dilution factor:
  ELISA: 1:5000-25000
  IHC: 1:500-2500
  WB: 1:5000-25000
  
  Note: Working dilution for specific application should be determined by the investigator to obtain the best conditions.

• Spezifikationen

  • Wirt

    Goat

    Klonalität

    Polyclonal

  • Immunogen

    Purified rabbit IgG

    Reaktivität

    Rabbit (Minor cross-reactivity to human in higher concentration)

  • Anwendung

    ELISA, IHC, WB

    Konjugation

    HRP

  • Lagerpuffer

    Phosphate Buffered Saline containing 1% BSA, 0.03% ProClin 300 and 50% glycerol, pH 7.4.

    Spezifität

    IgG

  • Form

    Liquid

• Anleitung

  • Versand

    The product is shipped with polar packs. Upon receipt, store it immediately at -20°C or lower for long term storage.

    Stabilität & Lagerung

    This product is stable after storage at:

    • 2-8°C for 2 weeks under sterile conditions from date of receipt.
    • -20°C or -80°C for 12 months under sterile conditions from date of receipt.

    Avoid repeated freeze/thaw cycles and protect from light.
    Suggestion: Divide antibody into several vials. Keep only vials for usage at 2-8°C.

• Bewertung

  

  Helfen Sie anderen, mehr über dieses Produkt zu erfahren. Nutzen Sie den Link unten, um Ihre Erfahrung zu teilen.

  Bewertung abgeben

• Publikation

  1. Kuthati Y et al. Antioxidants (Basel). 2023; 12(7):1478.
  2. Chen JC et al. Int J Mol Sci. 2023; 24(1):839.
  3. Jan MW et al. Viruses. 2022; 14(7):1499.
  4. Chiu CC et al. Cancers (Basel). 2022; 14(10):2528.
  5. Lai YC et al. Frontiers in immunology. 2022; 13:868724.
  6. Lee YK et al. Viruses. 2022; 14(2):330.
  7. Cheng YW et al. Journal of Biomedical Science. 2022; 29(1):10.
  8. Yang KS et al. Mol Med Rep. 2022; 25(1):36.
  9. Kuthati Y et al. Antioxidants (Basel). 2021; 10(9):1438.
  10. Kuthati Y et al. Antioxidants (Basel). 2021; 10(2):195.
  11. Shin SJ et al. Metabolism. 2020; 113:154403.
  12. Liu W et al. Oxid Med Cell Longev. 2020; 2020:5167292.
  13. Li NS et al. ACS Appl Bio Mater. 2019; 2(11):4847-4855.
  14. Hsieh MJ et al. Int J Oncol. 2019; 55(4):949-959.
  15. Chang WT et al. Int J Mol Sci. 2019; 20(17):4292.
  16. Kuthati Y et al. J Pain Res. 2019; 12:2473-2485.
  17. Kuthati Y et al. Int J Nanomedicine. 2019; 14:10105-10117.
  18. Chou CK et al. Environ Toxicol. 2019; 34(4):401-414.
  19. Chou CK et al. Int J Mol Sci. 2018; 19(7):1832.
  20. Chao CH et al. Shock. 2018; 50(1):103-111.
  21. Chiu YH et al. Int J Oncol. 2018; 53(5):1967-1979.
  22. Lai YC et al. Antiviral Res. 2018; 155:28-38.
  23. Chang WT et al. Anticancer Agents Med Chem. 2017; 17(5):692-700.
  24. Lai YC et al. Sci Rep. 2017; 7(1):6975.
  25. Chang WT et al. Molecules. 2017; 22(5):854.
  26. Chen HR et al. PLoS Negl Trop Dis. 2016; 10(7):e0004828.
  27. Chou HL et al. Arch Immunol Ther Exp (Warsz). 2016; 65(3):241-252.
  28. Chou HL et al. Oxid Med Cell Longev. 2016; 2016:9128102.
  29. Lo YL et al. RSC Adv. 2016; 6(44): 38209-38222.
  30. Lai YC et al. Cell Death Dis. 2015; 6(12):e2008.
  31. Chen HR et al. Biol Open. 2015; 4(2):244-52.
  32. Chuang YC et al. J Virol. 2014; 88(23):13759-68.

  Weitere Publikationen

  Weniger Publikationen

  Publikation einreichen

• Datenblatt & Dokumente

  Datenblatt

  MSDS

  Handbuch

  1

  /

  1

Haftungsausschluss：For Research Use or Further Manufacturing Only.